华法林基因导向药物遗传学给药的疗效和安全性的荟萃分析。 - Suppr | 超能文献

相似文献

1

Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.华法林基因导向药物遗传学给药的疗效和安全性的荟萃分析。

Int J Cardiol. 2014 Dec 15;177(2):654-7. doi: 10.1016/j.ijcard.2014.09.174. Epub 2014 Oct 7.

2

Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?华法林药物基因组学试验：药物基因组学指导剂量是否有未来？

Pharmacogenomics. 2014 Apr;15(6):719-22. doi: 10.2217/pgs.14.18.

3

[Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: the first meta-analysis of Russian prospective studies].[药物基因检测对华法林使用中出血风险和过度低凝事件的影响：俄罗斯前瞻性研究的首次荟萃分析]

Ter Arkh. 2014;86(4):64-71.

4

Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.抗凝治疗前进行基因检测？华法林药物基因组剂量学的系统评价。

J Gen Intern Med. 2009 May;24(5):656-64. doi: 10.1007/s11606-009-0949-1. Epub 2009 Mar 21.

5

Pharmacogenetics-based warfarin dosing algorithm decreases time to stable anticoagulation and the risk of major hemorrhage: an updated meta-analysis of randomized controlled trials.基于药物遗传学的华法林给药算法可缩短达到稳定抗凝的时间并降低大出血风险：一项随机对照试验的更新荟萃分析。

J Cardiovasc Pharmacol. 2015 Apr;65(4):364-70. doi: 10.1097/FJC.0000000000000204.

6

Outcomes of pharmacogenetics-guided dosing of warfarin: a systematic review and meta-analysis.华法林药物基因组学指导剂量给药的结果：一项系统评价和荟萃分析。

Int J Cardiol. 2014 Aug 20;175(3):587-91. doi: 10.1016/j.ijcard.2014.06.031. Epub 2014 Jun 28.

7

Pharmacogenomics and warfarin therapy.药物基因组学与华法林治疗

Issues Emerg Health Technol. 2007 Oct(104):1-8.

8

Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.华法林基因分型指导剂量与传统剂量的比较：15项随机对照试验的荟萃分析。

J Clin Pharm Ther. 2019 Apr;44(2):197-208. doi: 10.1111/jcpt.12782. Epub 2018 Dec 28.

9

Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.与标准疗法相比，基因型指导的华法林起始剂量算法的临床效用有限：一项对11项随机对照试验的荟萃分析和试验序贯分析。

Pharmacogenomics J. 2015 Dec;15(6):496-504. doi: 10.1038/tpj.2015.16. Epub 2015 Apr 14.

10

Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials.基于药物遗传算法的华法林剂量调整的临床益处：随机对照试验的荟萃分析

Thromb Res. 2015 Apr;135(4):621-9. doi: 10.1016/j.thromres.2015.01.018. Epub 2015 Jan 17.

引用本文的文献

1

Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences.口服抗凝药物：关于疗效和安全性、基因分型、自我监测以及利益相关者体验的系统评价综述。

Syst Rev. 2022 Oct 28;11(1):232. doi: 10.1186/s13643-022-02098-w.

2

Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease.PSRC1、CELSR2和SORT1基因多态性对华法林剂量变异性及心血管疾病易感性的影响。

Pharmgenomics Pers Med. 2020 Nov 17;13:619-632. doi: 10.2147/PGPM.S274246. eCollection 2020.

3

Precision dosing of warfarin: open questions and strategies.